Interview med CEO Thomas K. Selsø fra Pharma Equity Group - Hvad skete der i 1. kvartal?
Pharma Equity Group havde første handelsdag den 28. marts 2023 på Nasdaq København. De har netop aflagt deres 1. kvartalsregnskab for 2023.
Hvad er Pharma Equity Group for et selskab, og hvorfor købte de selskabet Reponex Pharmaceuticals? Dette og flere andre spørgsmål besvarer CEO Thomas K. Selsø i dette interview.
Lyt til interview her: https://www.inderes.dk/videos/pharma-equity-group-praesentation-af-q1-kvartalsregnskabet-2023
Disclaimer:
HC Andersen Capital modtager betaling fra Pharma Equity Group for en Digital IR/Corporate Visibility abonnementsaftale. /ANALYTIKER Claus Thestrup kl. 11:00 d. 15/5-2023
Pharma Equity Group
Pharma Equity Group develops new medicines for the local treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The company uses repositioning of existing drugs and brings drug candidates to a clinical phase III stage, after which it is handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the company.
Read more on company page